Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lovekirat Singh Dhaliwal"'
Autor:
Aswani Thurlapati, Lovekirat Singh Dhaliwal, Sumasri Chennapragada, Pranavteja Gutta, Diana Song, Deepika Ralla, Jill Comeau, Runhua Shi, Kavitha Beedupalli
Publikováno v:
Journal of Clinical Oncology. 40:8550-8550
8550 Background: The PACIFIC study (PS) concluded that the use of durvalumab from 1 to 42 days after concurrent chemoradiotherapy (CXRT) in stage 3 unresectable non-small cell lung cancer (NSCLC) increased the median overall survival (mOS) from 29 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeba66e5cbf008168e6d52196ce81d21
https://doi.org/10.1200/jco.2022.40.16_suppl.8550
https://doi.org/10.1200/jco.2022.40.16_suppl.8550
Autor:
Udhayvir Singh Grewal, Danya Ahmed, Lovekirat Singh Dhaliwal, Daniel A. Laheru, Emil Lou, Muhammad Shaalan Beg, Ryan David Nipp, Arjun Gupta
Publikováno v:
Journal of Clinical Oncology. 40:534-534
534 Background: Incorporating PROs into CTs is critical for patients with pancreatic cancer, as these individuals often experience a high symptom burden and prioritize maximizing quality of life (QOL). Methods: We reviewed protocols of completed U.S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fc72006611206cf538934dd27758e64
https://doi.org/10.1200/jco.2022.40.4_suppl.534
https://doi.org/10.1200/jco.2022.40.4_suppl.534